跳至主要内容
临床试验/NCT03394716
NCT03394716终止不适用

Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors

The Netherlands Cancer Institute1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2018年1月12日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
45
试验地点
1
主要终点
MRI parameters in the target volume

研究概览

简要总结

This study aims to evaluate anatomical and functional changes during RT for patients receiving fractionated RT for brain tumors. Anatomical changes during RT will be registered and analyzed and if needed the radiotherapy plan will be modified for the individual patient. This means that the "to be irradiated volume" will be modified according to the shape changes of the tumor. The functional MRI sequences will be used to evaluate what parameters, and at which time point, are important for radiotherapy outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary brain tumor (WHO IV, GBM); treated with fractionated radiotherapy with or without preceding surgery. Systemic treatment is allowed before and during radiotherapy.
  • Brain metastasis (from a solid extracranial tumor) eligible for treatment with fractionated radiotherapy with or without preceding surgery. Systemic treatment is allowed before and during radiotherapy.
  • Also, postoperative patients with a macroscopic residual tumor lesion can be included (the diagnosis of residual diseases is defined by the treating neurosurgeon or on the MRI executed within 24 hours after the surgery, the diagnosis of residual macroscopic disease should always be confirmed during the neuro-oncology multidisciplinary meeting).

排除标准

  • Patients receiving Whole Brain RT (WBRT)
  • Patient with a poor kidney function (GFR < 30 mL/min; CKD 4 and 5; patients on dialysis and patients with acute kidney insufficiency)
  • None, doubtful or very small (<5 mm in its largest dimension) contrast enhancing lesion
  • Patients with a contraindication for MRI

结局指标

主要结局

MRI parameters in the target volume

时间窗: through study completion, an average of 3 years

functional MRI parameters (permeability, perfusion and diffusion) in the target volume before and during fractional radiotherapy treatment

anatomical variations in position, shape and size in the target volume

时间窗: through study completion, an average of 3 years

The difference is position shape and size in the target volume before and during fractional radiotherapy treatment. In case there is no macroscopic extension beyond the clinical target volume the new target volumes (gross target volume (GTV) and clinical target volume (CTV).) will also (but later) be delineated for analysis of volume changes, center of mass changes and distance measurements between the delineation on planning MRI versus repeated MRI.

次要结局

  • the correlation between MRI parameters to the treatment outcome(through study completion, an average of 3 years)
  • the correlation between anatomical variations and the treatment outcome(through study completion, an average of 3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验